AMS · PHIA.AS
Koninklijke Philips N.V.
€24.41+€0.13 (+0.54%)
Koninklijke Philips N.V.’s quoted price sits in the upper half of its reported 52-week range, 11.88% below the high.
Loading market information…
OTC · DMSI · USD
Stock price
Quote as of Oct 29, 2026, 08:00 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
Dermisonics, Inc.’s quoted price sits in the upper half of its reported 52-week range, 0.0% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE COMPANY BEHIND THE TICKER
Dermisonics, Inc. develops and produces ultrasonic technologies and equipment for the transdermal administration of medications. A core focus for the company is the creation, evaluation, and market launch of its unique active transdermal patch, known as the U-Strip. This innovative patch is designed to facilitate the needle-free entry of large molecular weight drugs, like Insulin, directly into the circulatory system. The firm was originally incorporated as Second Stage Ventures, Inc. before adopting its current name, Dermisonics, Inc., in October 2004. Founded in 2000, the company maintains its principal offices in Irvine, California.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 02:16 PM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
€24.41+€0.13 (+0.54%)
Koninklijke Philips N.V.’s quoted price sits in the upper half of its reported 52-week range, 11.88% below the high.
CHF 283.60+CHF 2.00 (+0.71%)
Sonova Holding AG’s quoted price sits in the upper half of its reported 52-week range, 0.98% below the high.
DKK 106.90-DKK 3.30 (-2.99%)
GN Store Nord A/S’s quoted price sits in the upper half of its reported 52-week range, 13.62% below the high.
SEK 195.60+SEK 7.80 (+4.15%)
CellaVision AB (publ)’s quoted price sits in the upper half of its reported 52-week range, 1.31% below the high.
SGD 0.07SGD 0.00 (0.0%)
Vicplas International Ltd’s quoted price sits in the lower half of its reported 52-week range, 35.64% below the high.
CA$0.04-CA$0.01 (-11.11%)
Medx Health Corp.’s quoted price sits in the lower half of its reported 52-week range, 42.86% below the high.
$0.00$0.00 (0.0%)
Health Sciences Group, Inc.’s quoted price sits in the upper half of its reported 52-week range, 0.0% below the high.
$0.00$0.00 (0.0%)
Rafina Innovations Inc.’s quoted price sits in the upper half of its reported 52-week range, 16.67% below the high.
